In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References New Directions in MS Research: New Therapeutic Approaches […]
Read News ArticleAuthor: Hoff Communications
Simvastatin (Zocor® and others)
In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References Experimental Medications: New S1P Receptor Modulators Company: […]
Read News ArticleIbudilast (MN-166)
In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References Experimental Medications: New S1P Receptor Modulators Company: […]
Read News ArticleEvobrutinib (M2951)
In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References Experimental Medications: New S1P Receptor Modulators Company: […]
Read News ArticleVumerity™ (diroximel fumarate)
In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References Experimental Medications: New S1P Receptor Modulators Company: […]
Read News ArticlePonesimod
In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References Experimental Medications: New S1P Receptor Modulators Company: […]
Read News ArticleOzanimod (formerly RPC1063)
In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References Experimental Medications: New S1P Receptor Modulators Company: […]
Read News ArticleTemelimab (formerly GNbAC1)
In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References Experimental Medications: Monoclonal Antibodies Company: GeNeuro SA […]
Read News ArticleUblituximab (also known as TG-1101)
In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References Experimental Medications: Monoclonal Antibodies Company: TG Therapeutics […]
Read News ArticleOpicinumab
In this Update Main Article Introduction FDA-Approved Medications Experimental Medications New Directions in MS Research Closing Notes Approved Disease-Modifying Therapies for MS (PDF) References Experimental Medications: Monoclonal Antibodies Company: Biogen 750 […]
Read News Article